Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction
- 9 May 2024
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 106, 117755
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01 CA233959, R01 CA247232)
This publication has 21 references indexed in Scilit:
- Structure‐Based Drug Design of Phenazopyridine Derivatives as Inhibitors of Rev1 Interactions in Translesion SynthesisChemMedChem, 2021
- HLTF Promotes Fork Reversal, Limiting Replication Stress Resistance and Preventing Multiple Mechanisms of Unrestrained DNA SynthesisMolecular Cell, 2020
- Virtual Pharmacophore Screening Identifies Small‐Molecule Inhibitors of the Rev1‐CT/RIR Protein–Protein InteractionChemMedChem, 2019
- The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition2019
- Structural Approach To Identify a Lead Scaffold That Targets the Translesion Synthesis Polymerase Rev1Journal of Chemical Information and Modeling, 2018
- Small molecule scaffolds that disrupt the Rev1-CT/RIR protein-protein interactionBioorganic & Medicinal Chemistry, 2018
- Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein−Protein InteractionACS Chemical Biology, 2017
- Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer ChemotherapeuticsJournal of Medicinal Chemistry, 2016
- Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion SynthesisBiochemistry, 2016
- Cellular Functions of DNA Polymerase ζ and Rev1 Protein2004